Description du projet
Une solution rapide contre la propagation des bactéries
Toute surface publique peut être traitée avec un composé spécial qui élimine toutes les bactéries avec lesquelles il entre en contact. Ces revêtements antimicrobiens sont très demandés depuis la pandémie de COVID-19. Par ailleurs, les infections nosocomiales provoquent des milliers de décès chaque année en Europe. C’est dans cette optique que le projet SAFE-ON, financé par le CER, entend commercialiser ses revêtements antimicrobiens intelligents. Cela implique la préparation de deux revêtements antimicrobiens basés sur des formulations commerciales utilisées dans les cathéters et les housses de poignées de porte (l’un à base d’hydrogels et l’autre de silicone), puis de tester leur capacité antimicrobienne. Le projet permettra de tester deux prototypes: un cathéter enduit et une housse de poignée de porte.
Objectif
Infectious diseases are a rapidly growing threat to humanity. For instance, the current COVID-19 pandemic, caused by the virus SARS-CoV-2, has already killed over 4.5 million people since 2019 and is taking a devastating socioeconomic toll around the world. Similarly, nosocomial infections are among the major causes of death and increased morbidity, causing thousands of deaths every year in Europe. Recently, the use of antimicrobial coatings has garnered increasing interest as a simple prophylactic strategy to combat these infectious diseases. In this PoC project, we aim advancing a new patented antimicrobial coating technology called SAFE-ON, into the pre-commercial stage, with the aim of demonstrating its breakthrough innovation potential and approaching its arrival to market.
The first part of this project encompasses optimization of SAFE-ON technology as highly efficient, smart antimicrobial coatings. This entails the preparation of two antimicrobial coatings based on commercial formulations used in catheters and door-handle covers (one based on hydrogels and the other, on silicone), and subsequent testing of their antimicrobial capacity. It also involves preparing the first two SAFE-ON prototypes: one coated catheter and one door-handle cover. The second part of SAFE-ON will be dedicated to intellectual property (IP) and market aspects needed for the pre-commercialization of this new technology for antimicrobial coatings. This study will include a freedom-to-operate analysis and a market study to identify the antimicrobial coating producers that could ultimately serve as manufacturing partners.
In this project we will design, fabricate and evaluate two innovative prototypes incorporating our iodine delivery platform, with the aim to assess the commercial viability of with antimicrobial SAFE-ON coatings, accelerate their market entry and ultimately, commercialize and further develop antimicrobial coatings and other biocide products based on our technology.
Champ scientifique
- natural sciencesbiological sciencesmicrobiologyvirology
- medical and health scienceshealth sciencespublic healthepidemiologypandemics
- medical and health scienceshealth sciencesinfectious diseasesRNA virusescoronaviruses
- engineering and technologymaterials engineeringcoating and films
- natural scienceschemical sciencesinorganic chemistryhalogens
Mots‑clés
Programme(s)
- HORIZON.1.1 - European Research Council (ERC) Main Programme
Régime de financement
HORIZON-ERC-POC - HORIZON ERC Proof of Concept GrantsInstitution d’accueil
08193 Cerdanyola Del Valles
Espagne